Dr. Guyguy Manangama

Stories

DR Congo tests Zaire-strain Ebola vaccine against Bundibugyo outbreak

Overseeing the BRAVO vaccination study

Congo's frontline health workers are still receiving the only Ebola vaccine available at scale, though it was designed for a different virus. The BRAVO study, which began September 19, is following 20,000 health workers in Ituri and North Kivu to see whether Ervebo protects them against Bundibugyo.

Updated Yesterday

Notable Quotes

Although ERVEBO was not originally developed to protect against Bundibugyo, preliminary data suggest that it may offer some degree of protection against the virus. In a race against time such as the one the DRC is currently facing, we must use every tool available to us.

from DR Congo tests Zaire-strain Ebola vaccine against Bundibugyo outbreak · Updated Yesterday

It is important to stress that this vaccine will not end the current outbreak. However, it may offer additional protection to those most exposed.

from DR Congo tests Zaire-strain Ebola vaccine against Bundibugyo outbreak · Updated Yesterday